Carly Kenselaar

Stock Analyst at Citigroup

(3.09)

# 1,209

Out of 4,754 analysts

6

Total ratings

80%

Success rate

70.72%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Carly Kenselaar

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	TVTX Travere Therapeutics	Maintains: Buy	$31 → $35	$19.80	+76.77%	5	Feb 24, 2025
	KRYS Krystal Biotech	Initiates: Buy	$160	$171.83	-6.88%	1	Oct 12, 2023

Travere Therapeutics

Feb 24, 2025

Maintains: Buy

Price Target: $31 → $35

Current: $19.80

Upside: +76.77%

Krystal Biotech

Oct 12, 2023

Initiates: Buy

Price Target: $160

Current: $171.83

Upside: -6.88%